Development of an Electrochemical CCL5 Chemokine Immunoplatform for Rapid Diagnosis of Multiple Sclerosis

Serum level of CCL5 chemokine is considered an emerging biomarker for multiple sclerosis (MS). Due to the lack of specific assays for this disease, the development of a point-of-care test for rapid detection of MS could lead to avoiding diagnostics delays. In this paper, we report the first electroc...

Descripción completa

Detalles Bibliográficos
Autores principales: Guerrero, Sara, Sánchez-Tirado, Esther, Agüí, Lourdes, González-Cortés, Araceli, Yáñez-Sedeño, Paloma, Pingarrón, José M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406078/
https://www.ncbi.nlm.nih.gov/pubmed/36005006
http://dx.doi.org/10.3390/bios12080610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406078/
https://www.ncbi.nlm.nih.gov/pubmed/36005006
http://dx.doi.org/10.3390/bios12080610

Ejemplares similares